Oral administration of Bifidobacterium alone improved tumour control to a degree comparable to that achieved with PD-L1-specific antibody therapy (checkpoint blockade), and combined treatment nearly abolished tumour outgrowth [99]. The gene discussed is CD274; the disease is neoplasm.